MedTrace Logo

Neoadjuvant Chemotherapy Response in Metaplastic Carcinoma of Triple Negative Breast Cancer

NCT04549584 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 3

Last updated 2020-12-17

No results posted yet for this study

Summary

prospective study for response of neoadjuvant chemotherapy in metaplastic carcinoma of triple negative breast cancer

Conditions

  • Metaplastic Breast Carcinoma

Interventions

DIAGNOSTIC_TEST

Vimentin/pan CK stain

Vimentin/pan CK stain positive/negative

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Hyeong Gon Moon · Seoul National University

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2020-12-16
Completion
2020-12-16

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04549584 on ClinicalTrials.gov